Directors (And Other Officers)
| Concept |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
As at 2023-03-27 |
|---|---|---|---|---|---|---|---|---|---|---|
| Directors (and other officers) | ||||||||||
| Information about directors (and corporate auditors) | ||||||||||
| Official title or position |
取締役（監査等委員）(注)2
|
取締役（監査等委員）(注)2
|
取締役創薬支援事業本部長 兼 知的財産・法務部長
|
代表取締役社長
|
取締役（監査等委員）(注)2
|
取締役研究開発本部長
|
取締役経営管理本部長兼経理部長兼人事総務部長 兼 CarnaBio USA, Inc. President
|
取締役（監査等委員）(注)2
|
取締役 研究開発本部臨床開発部長 兼 CarnaBio USA, Inc. Chief Development Officer
|
— |
| Name |
有田 篤雄
|
松井 隆雄
|
相川 法男
|
吉野 公一郎
|
髙柳 輝夫
|
澤 匡明
|
山本 詠美
|
小笠原 嗣朗
|
有村 昭典
|
— |
| Date of birth |
1943-07-15
|
1956-04-08
|
1948-10-23
|
1949-03-25
|
1946-10-04
|
1970-12-07
|
1970-06-11
|
1939-07-23
|
1963-01-26
|
— |
| Career summary | — | |||||||||
| Term of office |
(注)4
|
(注)4
|
(注)3
|
(注)3
|
(注)4
|
(注)3
|
(注)3
|
(注)4
|
(注)3
|
— |
| Number of shares held (Ordinary shares) |
8,000
xbrli:shares
|
xbrli:shares
|
94,500
xbrli:shares
|
324,100
xbrli:shares
|
1,100
xbrli:shares
|
98,200
xbrli:shares
|
47,100
xbrli:shares
|
5,000
xbrli:shares
|
10,000
xbrli:shares
|
588,000
xbrli:shares
|